NCT04414865 - VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

April 26, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 30, 2027

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

VitaFlow™ Transcatheter Aortic Valve System

VitaFlow™ Transcatheter Aortic Valve System contains a valve stent-VitaFlow™ Aortic Valve, a delivery system-VitaFlow™ Delivery System,loading tools, a balloon dilatation catheter, and an introducer set

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Ruijing Hospital，Jiaotong University School of Medicine, Shanghai

RECRUITING

Zhongshan Hospital, Shanghai

All Listed Sponsors

lead

Shanghai MicroPort CardioFlow Medtech Co., Ltd.

INDUSTRY